The Sabin Vaccine Institute’s leadership team is comprised of a diverse group of global health, development and international relations experts.

Executive Staff

Amy Finan
Chief Executive Officer

Brian Davis, CPA
Chief Financial & Operating Officer


Senior Staff

Maria Bianchi
Director, Administration

Vince Blaser, MA
Director, Advocacy & Outreach

Courtney Finch, PhD
Principal Research Scientist, Research & Development

Denise Garrett, MD, MSc
Vice President, Applied Epidemiology

Jenna Groman, MA
Director, Global Communities of Practice

Tara Hayward, MA
Vice President, Resource Development & Policy

Kate Hopkins, PhD, MPH
Director of Research, Vaccine Acceptance & Demand

Jocelyn Jakubik, PhD
Senior Director, Clinical Trials and Clinical Quality Assurance

Brigitte Kellar, MBA, MS
Senior Director, Clinical Trials and Clinical Quality Assurance

Thomas King, PhD
Vice President, Research & Development

Stacey Knobler, MSc
Vice President, Vaccine Innovation & Global Immunization

Heather Ross, MPH
Director, Technical Writing
Roxana Rustomjee, MB, ChB, FCPHM,
MMed, PhD

Senior Vice President, Research & Development

Jennifer (Fluder) Siler, MBA
Vice President, Global Community Engagement

Paul L. Smock, MS
Senior Director, Quality Assurance and Chemistry,
Manufacturing and Controls Oversight

Ekaterina Vert-Wong, EVP, PMP, MEM, MSc
Vice President, Research & Development Operations

Michelle Williams, MBA
Vice President, Employee Engagement

 


Amy Finan

Chief Executive Officer

Amy Finan joined the Sabin Vaccine Institute as Chief Executive Officer in April 2016. In her time as CEO, Amy has led the development and implementation of a new organizational strategy focusing Sabin on a mission to make vaccines more accessible, enable innovation and expand immunization across the globe. Under Amy’s leadership, Sabin has rebuilt its vaccine research and development and global immunization programs, while diversifying and expanding its funder base, reinvigorating the Sabin brand and growing its Board of Trustees and staff. 

Most notably, in 2019 Sabin launched its new R&D program by securing a license from GSK to continue the development of vaccines against the deadly Ebola Sudan and Marburg viruses, then securing a U.S. Government contract to fund the development. Sabin also has successfully rebuilt its immunization programs and fortified relationships with global organizations such as the World Health Organization; Gavi, the Vaccine Alliance; UNICEF; the Bill & Melinda Gates Foundation and Wellcome Trust, as well as with country leadership. Specific programs include a revitalized network for immunization professionals, expanded disease surveillance programs to give countries the data they need to make vaccine introduction decisions, and educational programs that equip journalists to report accurately on vaccines.

Prior to joining Sabin, Amy served as senior vice president responsible for business development at the Biotechnology Innovation Organization (BIO). During her 11-year tenure, she played a critical role in expanding BIO’s membership and revenue base and implementing innovative approaches to fundraising, branding, marketing and programming. For two years and simultaneous with her BIO responsibilities, she also served as president of the Biotechnology Institute, an organization founded by BIO to promote life science education.

Prior to BIO, Amy led corporate communications and investor relations for the former clinical-stage biotechnology company EntreMed, Inc., created and implemented a biotech initiative for Montgomery County, Maryland, and served as a government relations director at the National Association for Biomedical Research.

Amy studied at the London School of Economics & Political Science and graduated with a bachelor’s degree in political science from Trinity College in Washington, D.C. A native of Columbus, Ohio, she has lived in the Washington, D.C., metropolitan area for more than 35 years and currently resides in Bethesda, Maryland, with her family.

Return to top


Brian Davis, CPA

Chief Financial & Operating Officer

Brian Davis has worked with the Sabin Vaccine Institute since 2005 and has served as its chief financial & operating officer since 2008. Prior to joining Sabin, Brian owned an established accounting practice in Washington, D.C. that served the non-profit sector in areas of life science, education, economic development and low-income housing. Brian holds CPA certificates in Maryland and the District of Columbia as well as a bachelor's degree in business administration with a major in finance from Michigan State University, and is a member of the American Institute of CPAs.

Return to top


Maria Bianchi

Director, Administration

Maria Bianchi is the director of Administration at the Sabin Vaccine Institute where she manages office operations. After traveling to Niger, Maria joined Sabin based on its mission to make a difference in the lives of the world’s children regardless of who they are or where they live. 

Prior to joining Sabin in 2009, Maria worked as the Operations Manager for RegNet Environmental Services for 13 years. Since 2005, she has served the Girl Scouts as a Service Unit Manager, Encampment Chair, Money Manager and Recognitions Chair in addition to being a scout leader for over a decade. Maria graduated from the State University of New York at New Paltz with a bachelor’s degree in elementary education with a major in English and a minor in art.

Return to top


Vince Blaser, MA

Director, Advocacy & Outreach

For more than 15 years, Vince Blaser has utilized a journalism and public policy background to raise the profile of global health programs and issues by initiating and growing partnerships. Prior to joining Sabin in July 2020 as Director of Advocacy & Outreach, he served in advocacy and policy leadership at IntraHealth International and directed the Frontline Health Workers Coalition, an alliance of more than 35 U.S.-based organizations advocating for greater and more strategic investment in frontline health workers in low- and middle-income countries. Previously, he worked in advocacy, policy and communications roles at the International AIDS Vaccine Initiative and the Global Health Council. Vince also has written and edited for the Kaiser Family Foundation’s daily reports on global health, held several positions as a newspaper reporter in Washington, D.C., and Colorado, and worked at the British Houses of Parliament in London. He has a bachelor’s degree in political science and journalism from Colorado State University and a master’s degree in international education development from Columbia University.

Return to top


Courtney Finch, PhD

Principal Research Scientist, Research & Development 

Dr. Courtney Finch is the principal research scientist for R&D. She brings more than 10 years of virus experience primarily studying vaccines and therapeutics. She has worked with animal models of disease and a wide range of viruses including filoviruses (such as Ebola virus and Marburg virus), influenza viruses and SARS-CoV-2 in a variety of containment environments, from Biosafety Level-2 to Biosafety Level-4 (BSL-4).

Prior to joining Sabin, Dr. Finch held positions at the U.S. Food and Drug Administration where she participated in the World Health Organization human serology program which selects the virus strains to be incorporated into the seasonal influenza vaccines. Next, she worked at the Integrated Research Facility in Frederick, MD, part of the Division of Clinical Research at the National Institute of Allergy and Infectious Diseases. As a study director there, she managed multi-disciplinary teams, designed and directed in vitro and in vivo studies and worked on multiple high-consequence viral pathogens requiring BSL-4 containment. Most recently, she served as Principal Scientist at AbViro, LLC, tasked with expanding their product portfolio and program management of these new products with the goal of moving products into clinical trials.

Courtney completed her undergraduate studies at the University of Virginia and her PhD in molecular and cell biology at the University of Maryland, College Park.

Return to top 


Denise Garrett, MD, MSc

Vice President, Applied Epidemiology

Dr. Denise Garrett is the vice president of Applied Epidemiology at the Sabin Vaccine Institute. In this role, she directs a team focused on generating epidemiological evidence to inform vaccine decision-making, optimize vaccine use and increase the impact of immunization. Since joining Sabin in 2015, she has successfully led the landmark multisite Surveillance of Enteric Fever in Asia Project (SEAP) and the Sero-epidemiology and Environmental Surveillance (SEES) study, served as the Secretariat Director for the Coalition against Typhoid and overseen several vaccine effectiveness studies in Pakistan and Brazil.

Denise brings extensive experience in program leadership and management, study design and implementation, technical assistance, infectious disease control and prevention, and outbreak response. Prior to joining Sabin, Denise worked at the U.S. Centers for Disease Control and Prevention (CDC) as a medical epidemiologist for more than 23 years, where she focused on international health and research, leading several multicenter research studies in both high- and low-resource settings. She has more than 100 professional publications in several high-impact public health and infectious disease journals, and frequently presents and serves on panels at international conferences and stakeholder meetings.

Denise received her medical training with a special focus on infectious diseases and a master’s degree in human biology from Brazil’s Federal University of Minas Gerais. She also participated in the U.S. CDC’s Epidemic Intelligence Service officer training program where she received training in the practice of applied epidemiology. 

Return to top


Jenna Groman headshotJenna Groman, MA

Director, Global Communities of Practice

Jenna Groman is the director of Global Communities of Practice at the Sabin Vaccine Institute. In this role, she leads projects designed to share and translate knowledge in support of immunization professionals to improve vaccine acceptance and demand. Jenna brings experience building and leading global communities of practice, working groups and other collaborative initiatives, bringing together NGOs, government officials, public health staff and industry partners to build capacity and accelerate program impact.

Prior to joining Sabin, Jenna served as global programs manager and membership programs manager at NetHope, where she directed public health and digital development programs with a focus on community and stakeholder collaboration. She previously worked at Gryphon Scientific and CNA, focusing on domestic and international public health preparedness, emergency management and humanitarian assistance. She has a master’s degree in Economics from Boston University and a bachelor’s degree from the University of Massachusetts, Amherst.

Return to top


Tara Hayward, MA

Vice President, Resource Development & Policy

Tara Hayward is vice president of Resource Development and Policy at the Sabin Vaccine Institute. She oversees fundraising and public policy activities supporting Sabin’s work to improve lives through immunization. With more than a decade of experience in non-profit fundraising, she has led Sabin’s efforts to secure funding from governments, foundations, corporations and high net worth individuals since 2010. 

Prior to joining Sabin, Tara served as the manager of development for the International Women's Media Foundation, where she was responsible for creating and managing the infrastructure and operations of annual giving, foundation and corporate fundraising, and special events. Her prior experience also includes working for the United Nations Population Fund in Bosnia and Herzegovina and serving in the Peace Corps in Romania.

Tara holds a master’s degree in international development from the University of Denver in the Josef Korbel School of International Studies and a bachelor’s degree from DePauw University, where she majored in English writing.

Return to top


Kate Hopkins, PhD, MPH 

Director of Research, Vaccine Acceptance & Demand

Dr. Kate Hopkins oversees the research programming across the Vaccine Acceptance & Demand team to implement program activities, expand and manage partnerships, invest in new research projects and continue the growth of Sabin’s thought leadership programming.

Prior to joining Sabin, Kate spent 11 years living and working in sub-Saharan Africa conducting infectious disease prevention and psychosocial-behavioral research and health service program implementation in low- and middle-income countries—with particular focus on high-risk and vulnerable populations. Managing multi-country and multidisciplinary teams, her past portfolio of work included supporting clinical research site operations and strengthening capacity for the conduct of HIV and COVID-19 vaccine clinical trials within the HIV Vaccine Trials Network and COVID-19 Prevention Network. Kate supported the implementation of the ENSEMBLE J&J Phase III clinical trial and the subsequent SISONKE J&J COVID-19 vaccination rollout amongst healthcare workers in South Africa.

Kate has been a joint-Faculty Researcher for the Faculty of Health Sciences, University of the Witwatersrand in Johannesburg, South Africa, for nine years; and is a virtual course lecturer on Operational Research within a post-graduate diploma program in TB/HIV Management for the University of Cape Town in South Africa. She was awarded funding for her PhD study from the CDC as a PEPFAR-funded activity under its Cooperative Agreement with the South African Medical Research Council, earning her degree from the University of the Witwatersrand School of Public Health. She also holds a Masters in Public Health, with a focus on Global Health, from Boston University School of Public Health.

Return to top


Jocelyn Jakubik, PhD

Senior Director, Analytical Testing and Translational Immunology, Research & Development

Dr. Jocelyn Jakubik is the Senior Director of Analytical Testing and Translational Immunology on the Research & Development team at the Sabin Vaccine Institute. In this role, she directs teams focused on Sabin’s candidate vaccines to protect against Ebola and Marburg. She oversees immune assay qualification and validation to support clinical vaccine immunogenicity and efficacy studies. Jocelyn also designs experiments to evaluate vaccine candidatesanddesigns critical reagents to optimize ELISAs and biofunctional cell-based neutralization antibody assays based upon ICH, GLP and GCLP compliance. Jocelyn is involved in both vaccine manufacturing and regulatory activities related to process characterization, enhanced productivity and analytics assay validation for vaccine products.

Jocelyn brings extensive contract research organization (CRO) assay development and high-throughput clinical testing experience, including program leadership and management, study design and implementation, technical assistance, assay troubleshooting and outbreak response. Prior to joining Sabin, Jocelyn worked at CROs including Pharmaceutical Product Development (PPD), and in biopharma at Wyeth/Pfizer, where she focused on leading vaccine clinical trials and process development.

Jocelyn earned her PhD with a focus on infectious diseases from Rush University Medical Center in Chicago, IL following her BS in Biochemistry from the University of Illinois.

Return to top


Brigitte Kellar, MBA, MS 

Brigitte Kellar Headshot

Senior Director, Clinical Trials and Clinical Quality Assurance

Brigitte Kellar is the senior director for Clinical Trials and Clinical Quality Assurance for Sabin’s Research & Development team. In this role, she is responsible for providing leadership, strategic vision and efficient execution in managing compliance related to Good Clinical Practices (GCP’s), Good Laboratory Practices (GLCP’s) and Good Pharmacovigilance Practices (GPVP’s).

Brigitte has more than 25 years of experience and is an expert in clinical operations management, study/site management, project management and clinical research monitoring. She has worked extensively in logistical and tactical activities related to study management in partnership with program managers, clinical trial managers, data managers, regulatory affairs, sales & marketing, biostatisticians, clinical safety, CMC, technical operations and lead clinical research associates. She is knowledgeable of clinical research regulations and a has a track record of implementing the necessary controls to ensure compliance. She is dedicated to maintaining a reputation built on quality, service, uncompromising ethics and improving patient lives/outcomes. Prior to joining Sabin, Brigitte was a pharmaceutical, biotechnology and medical device consultant at Clin-Foci, Inc., serving clients across the United States.

Brigitte is a member of the Regulatory Affairs Professionals Society (RAPS). She holds a diploma of nursing, a bachelor’s of science degree in microbiology a master’s degree in regulatory sciences and a Master of Business Administration.

Return to top


Thomas King, PhD

Vice President, Research & Development

Dr. Tom King joined the Sabin Vaccine Institute as the vice president of Research & Development in December 2021 to oversee vaccine development initiatives. Tom aims to add new products to Sabin’s vaccine pipeline to help address infectious diseases that fulfill unmet needs.

As an established leader in vaccine development with a 25-year background in industrial biotechnology, he has served as the R&D Director at private and publicly traded companies including ImmunityBio and GlobeImmune since 2011. Through these roles, Tom created animal models to study the immunogenicity of adenoviral, microbial, and subunit vaccine platforms combined with protein-based immune modulation. These products were developed clinically against 8 different infectious disease and cancer targets. Tom and his teams shepherded these new products from discovery through IND, leading to 20 phase 1 and 2 FDA-regulated clinical trials. Success in these ventures required close collaboration with manufacturing, regulatory, and quality groups at Gilead Sciences, Celgene, ImmunityBio, GlobeImmune, the National Cancer Institute, Colorado State University, and BioPlx Microbiomics. These team efforts ensured the completion of complex deliverables that supported the acquisition of $250 million in funds and proceeds to propel innovation.

Tom earned his PhD in 2001 at the University of Massachusetts, Amherst and is an inventor/author of 46 patents and peer-reviewed publications. He is eager to strategically leverage his experience towards better health and quality of life for those in emerging economies by creating more efficacious vaccines that are affordable and accessible to all.

Return to top


Stacey Knobler, MSc

Vice President, Vaccine Innovation & Global Immunization

Stacey Knobler joined Sabin in 2018 to lead an initiative dedicated to accelerating the development of a universal influenza vaccine. Stacey has more than 20 years of experience as a global health and development professional, with expertise in research, program design and implementation, and strategic planning. She previously served as a Senior Adviser and Scientific Program Director for multiple large-scale initiatives for the Division of International Epidemiology and Population Studies at the Fogarty International Center (FIC), within the U.S. National Institutes of Health (NIH).

Stacey has been recognized for her leadership of research and outreach activities that have effectively engaged stakeholders from multiple sectors, integrated numerous academic disciplines and translated scientific findings for application within a broad range of communities. Stacey has received numerous awards for outstanding achievement and distinguished service to the U.S. Institute of Medicine and the National Academy of Sciences, as well as the FIC Director’s Outstanding Service Award and the FIC Director’s Special Award for Mentorship. She has over 40 professional publications and has served on the editorial review committees of several public health and infectious disease journals. Stacey is currently the President of the Board for the American Friends of the London School of Hygiene and Tropical Medicine. She received bachelor’s degrees in molecular genetics and political science from the University of Rochester in New York, and master’s degrees in epidemiology and public health from the London School of Hygiene and Tropical Medicine.

Return to top


Heather Ross, MPH

Director, Technical Writing

Heather Ross joined the Sabin Vaccine Institute in 2020 to lead technical writing of Sabin’s proposals and reports, and support strategic development and design of educational resources for health workers, journalists and advocates. Heather brings extensive experience in program design and proposal development for U.S. Federal Government agencies, international funding bodies, foundational and private donors. She has written or co-written more than 60 proposals, multiple reports and peer-reviewed journal articles regarding educational quality and health access equity. Additionally, since 2014 Heather has served as an adjunct professor of global health at The George Washington University, teaching graduate classes in comparative international health systems.

Before joining Sabin, Heather was Senior Technical Writer and previously Senior Technical Advisor for health workforce development at IntraHealth International. During her tenure as technical advisor, Heather co-wrote methodologies for educational evaluation and strategic planning, and contributed to evaluation and quality improvement of medical and nursing education globally. She has guided curriculum design and evaluation at the policy level as well as institutional quality improvement in more than 100 schools of medicine and nursing in 20 countries. She capitalized on her deep technical knowledge of health systems and education to contribute to program planning and lead proposal writing efforts for IntraHealth while building organization-wide capacity to communicate cohesive technical strategies. Prior to IntraHealth, as research manager for the global coordinating center at the Medical Education Partnership Initiative (MEPI) Heather contributed to development and implementation of internationally comparable educational evaluation of MEPI-affiliated schools of medicine in 13 sub-Saharan African countries.

Heather holds a master’s degree in public health from The George Washington University with dual concentrations in global health and epidemiology.

Return to top


Roxana Rustomjee, MB, ChB, FCPHM, MMed, PhD

Senior Vice President, Research & Development

Dr. Roxana Rustomjee joined the Sabin Vaccine Institute as the senior vice president of research & development as of November 2019. She is a leader in the global health community and is committed to ensuring that people in low- and middle-income countries have access to vaccines. Throughout her impressive 20-year career as an infectious disease physician and clinical epidemiologist, Roxana has led teams of researchers, governments, private sector and non-governmental organizations worldwide to develop vaccines, drugs and diagnostics and move them closer to patients. She has served as the principal investigator of multiple research grants and led strategic product development partnerships with the private sector and government funding agencies.

Roxana has extensive experience effectively managing large, multi-country teams to accelerate biopharmaceutical product development and licensure. She has led global clinical trial networks across five continents, conducting trials in most countries with a high burden of infectious diseases as senior scientist at the Tuberculosis Clinical Research Branch within the Division of AIDS at the U.S. National Institutes of Health. Roxana has supported the development and introduction of new vaccines, therapeutics and diagnostics for infectious diseases as head of the Office of HIV and Tuberculosis Research at the South African Medical Research Council, and she has delivered innovative trial designs for a novel tuberculosis vaccine in her role as senior director of clinical strategy in the BioSciences Division of Emergent Biosolutions UK/USA.

Using her experience addressing the needs and challenges of low- and middle-income countries, Roxana has taken a prominent role in defining health policy and translating research to advocate for change. She has served on a number of expert working groups with the World Health Organization, USAID and others, and on boards including that of The Biologicals and Vaccines (Biovac) Institute of Southern Africa (Proprietary Limited), where Roxana helped steer this relatively new public-private partnership to build a portfolio of more than 10 different vaccines and ultimately to supply South Africa with more than 25 million doses of vaccines annually.

Partnerships have been foundational to Roxana’s success. She has successfully organized, won and managed large multi-centered international grants with collaborators from governments, universities, private sector, non-governmental, and global health organizations.

Roxana is an infectious disease physician with a degree from the Nelson R. Mandela School of Medicine at the University of KwaZulu-Natal South Africa. She received her doctorate in epidemiology from Columbia University Mailman School of Public Health in New York. Roxana has published more than 60 peer-reviewed publications.

 

Return to top


Jennifer (Fluder) Siler, MBA

Vice President, Global Community Engagement

Jennifer (Fluder) Siler currently serves as the vice president of Global Community Engagement and leads Boost, a global community where immunization professionals connect, learn and lead. Before Sabin, Jennifer served as the Innovation Team lead and senior partnership advisor in the Global Health Bureau at the United States Agency for International Development (USAID). She led USAID's innovation investments in the Ebola and Zika crises, launched one-of-a-kind partnerships with Facebook, GlaxoSmithKline and DuPont, and developed multi-donor strategy and community of practice for unmanned aerial systems in global health.

Jennifer has also worked at two national healthcare nonprofits in development and strategy, focusing on program development for patients and donors, as well at Edelman PR in brand experience and corporate social responsibility for private sector companies. She has pursued several global health fellowships in Kenya, South Africa and India with Innovations in Healthcare, OperationASHA, Jacaranda Maternal Health and Ubuntu. Jennifer has a master’s degree in business administration from Duke University’s Fuqua School of Business specializing in social entrepreneurship in global health.

Return to top


Paul L. Smock, MS

Senior Director, Quality Assurance and Chemistry, Manufacturing and Controls Oversight

Paul Smock leads quality assurance and oversees chemistry, manufacturing and controls (CMC) as a part of Sabin’s research & development team. Most recently, Paul was a biotechnology quality & technical consultant at Meridian BioGroup, LLC., serving clients in Maryland and across the United States. Previously he had been Senior Director, Technical Quality at AstraZeneca Biologics (MedImmune, LLC) providing science and risk-based quality leadership and direction for biologics operations across the enterprise. Also at MedImmune, he was Senior Director, Quality Assurance (Site Head) for the Frederick Manufacturing Center (2011 FOYA Winner) for the start-up, licensure and transition to multi-product clinical/commercial operations phases of this facility. Paul has more than 40 years of experience in the biotechnology industry spanning biopharmaceuticals, vaccines, validation consulting, and in-vitro diagnostic businesses. He has previously held management and technical positions in QA/QC, Validation, Process Development, and Manufacturing at Wyeth Biotech, Serono Laboratories, Triad Technologies, and the DuPont Company. Paul is a 25-year member of the International Society for Pharmaceutical Engineering (ISPE), past president of the Boston Area Chapter and is currently a board member of the ISPE Chesapeake Bay Chapter. He holds a bachelor’s of science degree in chemistry and mathematics from the University of Michigan, a master’s degree in clinical chemistry from the University of Dayton and has served as an adjunct faculty member at Mount St. Mary’s University.

Return to top


Ekaterina Vert-Wong, EVP, PMP, MEM, MSc

Vice President, Research & Development Operations

Ekaterina Vert-Wong is the vice president of Research & Development Operations at the Sabin Vaccine Institute. In this role, she leads operational, organizational and alliance management functions. Since joining Sabin in 2021, she oversees R&D programs planning and execution and leads the development teams in the implementation of efficient operations and cost-effective systems to meet current and future needs of the organization. Ekaterina fosters Sabin’s internal and external collaborations to move vaccine development milestones forward, secure funding, and implement long-term pipeline strategies, internally and externally via effective alliance management.

Ekaterina brings excellent knowledge of global vaccines R&D practices, proven record of success in leading medical innovation, including execution of all clinical phases and design of global regulatory strategies. Prior to joining Sabin, Ekaterina lead departments within innovative and dynamic research organizations, focusing on the development and testing of vaccines and biologics. She has more than 20 years of experience in product development, including development and licensure of BioThrax® for post-exposure prophylaxis and pre-exposure use in special populations at Emergent BioSolutions and development of anti-pertussis antibodies for passive vaccination applications under the alliance with the Gates Foundation she created while at Synthetic Biologics.

Ekaterina received her graduate degree in Management from Dartmouth College and a graduate degree in Biochemistry from the Weizmann Institute of Science in Israel. Ekaterina is a dedicated medical innovator committed to bringing vaccines with high societal impacts to patients in need via ethical and equitable research pathways.

Return to top


Michelle Williams, MBA

Vice President, Employee Engagement

Michelle Williams joined the Sabin Vaccine Institute as vice president of employee engagement in 2020. Michelle has worked in the non-profit industry for more than 25 years, in a number of capacities including diversity, equity and inclusion, human resources management, talent development and optimization, training and organizational development, fundraising, and event management. She considers herself fortunate to have worked at organizations with causes close to her heart: welfare to work, community reinvestment, American farming and sustainability, health education, human anti-trafficking, and now vaccines and immunization.

Prior to coming to Sabin, Michelle founded and operated Conscientious Coaching and Consulting (CCC), a boutique firm providing non-profit organizations and small businesses with cost-effective human resources strategies tailored to meet the needs of the business. “Building healthy, diverse, equitable, and inclusive workplaces one individual and one organization at a time.”

Michelle earned her master’s degree in business administration with a concentration in management and a bachelor’s degree in business administration with a concentration in marketing from Howard University in Washington, D.C., where she graduated with honors.

Return to top